Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Continued research into synthetic peptides helps expand scientific understanding of peptide chemistry and cellular signaling mechanisms within controlled laboratory environments
Semaglutide should be discontinued at least 2 months before a planned pregnancy, as weight loss is not recommended during pregnancy
Semaglutide has a terminal half-life of approximately 1 week (about 7 days or 168 hours), according to FDA prescribing information
Decisions on appropriate use may be made taking into consideration the glycemic parameters together with the status of CV and renal comorbidity and clinically relevant considerations, such as risk of hypoglycemia and weight gain
Acting on GLP-1 and GIP receptors, retatrutide promotes delayed gastric emptying and sends hunger-reducing signals to the brain
